BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 8198522)

  • 1. Regulation of aflatoxin B1-metabolizing aldehyde reductase and glutathione S-transferase by chemoprotectors.
    McLellan LI; Judah DJ; Neal GE; Hayes JD
    Biochem J; 1994 May; 300 ( Pt 1)(Pt 1):117-24. PubMed ID: 8198522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of glutathione S-transferases and aldehyde reductase by chemoprotectors: studies of mechanisms responsible for inducible resistance to aflatoxin B1.
    Hayes JD; McLeod R; Ellis EM; Pulford DJ; Ireland LS; McLellan LI; Judah DJ; Manson MM; Neal GE
    IARC Sci Publ; 1996; (139):175-87. PubMed ID: 8923030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethoxyquin-induced resistance to aflatoxin B1 in the rat is associated with the expression of a novel alpha-class glutathione S-transferase subunit, Yc2, which possesses high catalytic activity for aflatoxin B1-8,9-epoxide.
    Hayes JD; Judah DJ; McLellan LI; Kerr LA; Peacock SD; Neal GE
    Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):385-98. PubMed ID: 1953636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver.
    Kelly VP; Ellis EM; Manson MM; Chanas SA; Moffat GJ; McLeod R; Judah DJ; Neal GE; Hayes JD
    Cancer Res; 2000 Feb; 60(4):957-69. PubMed ID: 10706111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to aflatoxin B1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin.
    Hayes JD; Judah DJ; Neal GE
    Cancer Res; 1993 Sep; 53(17):3887-94. PubMed ID: 8395332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases.
    Kensler TW; Egner PA; Davidson NE; Roebuck BD; Pikul A; Groopman JD
    Cancer Res; 1986 Aug; 46(8):3924-31. PubMed ID: 2873884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione.
    Kensler TW; Egner PA; Trush MA; Bueding E; Groopman JD
    Carcinogenesis; 1985 May; 6(5):759-63. PubMed ID: 3924431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of rat glutathione S-transferase A5 by cancer chemopreventive agents: mechanisms of inducible resistance to aflatoxin B1.
    Hayes JD; Pulford DJ; Ellis EM; McLeod R; James RF; SeidegÄrd J; Mosialou E; Jernström B; Neal GE
    Chem Biol Interact; 1998 Apr; 111-112():51-67. PubMed ID: 9679543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism.
    Manson MM; Ball HW; Barrett MC; Clark HL; Judah DJ; Williamson G; Neal GE
    Carcinogenesis; 1997 Sep; 18(9):1729-38. PubMed ID: 9328168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indole-3-carbinol induces a rat liver glutathione transferase subunit (Yc2) with high activity toward aflatoxin B1 exo-epoxide. Association with reduced levels of hepatic aflatoxin-DNA adducts in vivo.
    Stresser DM; Williams DE; McLellan LI; Harris TM; Bailey GS
    Drug Metab Dispos; 1994; 22(3):392-9. PubMed ID: 8070315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and heterologous expression of a cDNA encoding a mouse glutathione S-transferase Yc subunit possessing high catalytic activity for aflatoxin B1-8,9-epoxide.
    Hayes JD; Judah DJ; Neal GE; Nguyen T
    Biochem J; 1992 Jul; 285 ( Pt 1)(Pt 1):173-80. PubMed ID: 1637297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ethoxyquin-inducible aldehyde reductase from rat liver that metabolizes aflatoxin B1 defines a subfamily of aldo-keto reductases.
    Ellis EM; Judah DJ; Neal GE; Hayes JD
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10350-4. PubMed ID: 8234296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases.
    Primiano T; Egner PA; Sutter TR; Kelloff GJ; Roebuck BD; Kensler TW
    Cancer Res; 1995 Oct; 55(19):4319-24. PubMed ID: 7671242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of mouse glutathione S-transferases by chemoprotectors. Molecular evidence for the existence of three distinct alpha-class glutathione S-transferase subunits, Ya1, Ya2, and Ya3, in mouse liver.
    McLellan LI; Kerr LA; Cronshaw AD; Hayes JD
    Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):461-9. PubMed ID: 2049074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
    Buetler TM; Bammler TK; Hayes JD; Eaton DL
    Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of aflatoxin B1 metabolic profiles and reduction of aflatoxin B1 mutagenicity by hepatic microsomes of rats fed butylated hydroxyanisole.
    Choi CY; Park SH; Park EH; Cha YN
    J Toxicol Sci; 1991 Feb; 16 Suppl 1():119-32. PubMed ID: 1920539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz.
    Buetler TM; Gallagher EP; Wang C; Stahl DL; Hayes JD; Eaton DL
    Toxicol Appl Pharmacol; 1995 Nov; 135(1):45-57. PubMed ID: 7482539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning of cDNAs from fetal rat liver encoding glutathione S-transferase Yc polypeptides. The Yc2 subunit is expressed in adult rat liver resistant to the hepatocarcinogen aflatoxin B1.
    Hayes JD; Nguyen T; Judah DJ; Petersson DG; Neal GE
    J Biol Chem; 1994 Aug; 269(32):20707-17. PubMed ID: 8051171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the hepatocarcinogenicity of aflatoxin B1 in rats by low levels of the phenolic antioxidants butylated hydroxyanisole and butylated hydroxytoluene.
    Williams GM; Iatropoulos MJ
    Cancer Lett; 1996 Jun; 104(1):49-53. PubMed ID: 8640745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of glutathione S-transferases Ya, Yb1, Yb2, Yc1 and Yc2 and microsomal epoxide hydrolase genes by thiazole, benzothiazole and benzothiadiazole.
    Kim SG; Cho MK
    Biochem Pharmacol; 1996 Dec; 52(12):1831-41. PubMed ID: 8951341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.